Genomics and acute myeloid leukaemia
Aggressive and complex, AML often proves a challenge for clinicians, but genomic analysis is helping in the search for targeted treatments
About GEP Admin
This author has yet to write their bio.Meanwhile lets just say that we are proud GEP Admin contributed a whooping 27 entries.
Entries by GEP Admin
All I want for Christmas is… a family history
19th December 2018 in Genomics in practice /by GEP AdminAt a time of year when many of us will be getting together with relatives, we explore the value of talking about your family’s health
Genomics, the land, and the promise of new drugs
11th December 2018 in Research /by GEP AdminDespite its proven value, scientists and researchers are yet to harness the full medical potential of the soil. Is genomics the key?
Birth of world’s first gene-edited babies sparks outcry
6th December 2018 in Research /by GEP AdminWhy is the procedure so controversial, what are the risks, and could it ever happen in the UK? We take a look at the key issues
Day in the life: clinical bioinformatician
23rd November 2018 in Day in the life /by GEP AdminIn the latest article in our series, Eileen Gallagher introduces the increasingly important role that bioinformatics plays in today’s healthcare system
Do our genes govern our fate?
19th November 2018 in Core concepts /by GEP AdminA ‘faulty’ gene can result in different outcomes for different people – penetrance and expressivity influence the impact of our genetic code
What is pharmacogenomics?
12th November 2018 in Core concepts /by GEP Admin… and how can clinicians take advantage of advances in genomics to better predict how their patient will respond to medication?
Delivering results: the patient perspective
5th November 2018 in Genomics in practice /by GEP AdminAs genomic testing becomes more prevalent, the ability to deliver results sensitively is paramount; so what matters to your patients and their families?
Unlocking the secrets of the genome
1st November 2018 in Research /by GEP AdminIt was once believed that 99% of our genome was made up of ‘junk’ DNA with no purpose. Recent discoveries suggest this is far from the truth
Polygenic risk scores: how useful are they?
25th October 2018 in Research /by GEP AdminBeing able to predict an individual’s risk of common conditions is regarded by many as the holy grail. So, where are we now?
Tuberculosis: genome sequencing and new treatment
15th October 2018 in Genomics in practice, Research /by GEP AdminTB cases are falling worldwide, but with hard-to-treat strains more prevalent than ever, how can genomics help? And what’s new on the treatment horizon?
Your invaluable genome
8th October 2018 in Expert view, Genomics in practice, Research /by GEP AdminGenomic data is the currency of a new era of medicine that promises incredible advances. Here, bioinformatician Nana Mensah explains why
Developing people
for health and
healthcare
